Why the study?
The European Society of Cardiology rapid rule-out and rule-in protocols using high-sensitivity cardiac troponins are widely used for evaluating non-ST-segment-elevation myocardial infarction, motivating an investigation to identify the best performing hs-cTn assay.
Population
10 prospective emergency department studies of patients evaluated for NSTEMI (n=8769 at 0/1-hour, n=1881 at 0/2-hour, n=1236 at 0/3-hour)
Comparison
10 hs-cTn assays across ESC 0/1-hour, 0/2-hour, and 0/3-hour rapid rule-out and rule-in algorithms
Design
Network meta-analysis of full-paired prospective diagnostic accuracy studies
Answers are grounded in this paper and cite their sources.
Supports rapid NSTEMI rule-out with the ESC 0/1-hour algorithm; confirms high sensitivity across hs-cTn assays in Level 1 evidence.
BACKGROUND: The European Society of Cardiology rapid rule-out and rule-in protocols using hs-cTns (high-sensitivity cardiac troponins) with blood collection at 0 and 1 hour (0/1 hour), 0 and 2 hours (0/2 hours), and 0 and 3 hours (0/3 hours) are accurate and widely used for evaluating non-ST-segment-elevation myocardial infarction. This network meta-analysis aimed to identify the best performing hs-cTn assay. METHODS: We conducted database searches up to January 15, 2026, a dual screening and eligibility assessment, independent data extraction and risk of bias assessment, a network meta-analysis of diagnostic accuracy, and assessment of the certainty of evidence. Only full-paired diagnostic accuracy studies conducted in the emergency department were included. RESULTS: Ten prospective studies (15 publications) comparing 10 assays using the 0-/1-hour algorithm (n=8769), 0-/2-hour algorithm (n=1881), and 0-/3-hour algorithm (n=1236) were included. Comparisons between newer and conventional assays largely stemmed from a single-source study. Across all assays, the European Society of Cardiology 0-/1-hour algorithm demonstrated high sensitivity (summary point estimate range: 97.8%-99.8%). Furthermore, it maintained high specificity (89.8%-98.1%), with no assay showing clear superiority. The summary sensitivity and specificity did not show significant differences across assays after adjusting for biases because of imperfect reference standards. Comparative data in the European Society of Cardiology 0-/2-hour and 0-/3-hour algorithms were limited. CONCLUSIONS: Evidence remains insufficient to establish the superiority of any specific hs-cTn assay within the European Society of Cardiology 0-/1-hour algorithm. Although practical considerations may currently guide selection, continued validation of newer assays remains necessary.
No takes yet. Share an insight, caveat, or question.
Ohtake et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: